Guide contents
Open in calculatorCompound briefing
Glutathione (γ-Glu-Cys-Gly) is the body's principal intracellular antioxidant and a critical cofactor for detoxification enzymes. It is studied for reducing oxidative stress, supporting liver function, modulating immune responses, and as an adjunctive skin-brightening agent through melanin-inhibiting mechanisms.
The research question
Glutathione participates directly in redox reactions and serves as a substrate for several detoxification enzymes. Research should measure defined oxidative, hepatic or melanin-related endpoints rather than relying on the broad label of master antioxidant.
Mechanism & research themes
Directly neutralises reactive oxygen species and regenerates other antioxidants (vitamins C and E). Serves as a substrate for glutathione peroxidase and glutathione S-transferase enzymes involved in phase II detoxification. In melanocytes, reduced glutathione shifts melanin production from eumelanin toward phaeomelanin.
Master antioxidant activity across multiple cellular compartments
Phase II detoxification support and xenobiotic clearance
Immune-cell function and inflammatory balance modulation
Skin-brightening and melanin-modulating effects in research
Liver and mitochondrial protection under oxidative challenge
Replenishes levels depleted by ageing, stress and environmental toxins
These are research themes reported across the literature, not established benefits or indications.
Evidence assessment
Its biochemical role is well established, but outcomes depend strongly on route, formulation and endpoint. Antioxidant capacity alone does not validate skin, detoxification or disease-treatment claims.
What to look for
Controlled design, a defined preparation, clinically relevant endpoints and independent replication carry more weight than a single mechanism study.
What not to assume
A plausible pathway does not establish efficacy. Results across different routes, formulations and populations are not automatically interchangeable.
Protocol literature
Commonly referenced research protocols use 200–600mg subcutaneously or intramuscularly per session, 1–3× weekly, or 600–1500mg weekly in divided doses. Skin-brightening research often uses higher-dose IV protocols under clinical supervision. Cycles typically run 4–12 weeks.
Reported persistence
Plasma half-life is short (minutes); intracellular pools replenish over hours to days with repeated dosing.
Calculator starting point
200 mg per reference dose
3 doses per week · 8-week cycle
5 mL default reconstitution volume
200–600 mg SC/IM 1–3×/week; protect from light after reconstitution.
Calculator defaults are editable mathematical reference values, not dosing advice. Verify all calculations independently.
Calculate GlutathioneLaboratory handling
Reconstitution reference
Reconstitute a 600mg vial with 3–6mL bacteriostatic water for a 100–200mg/mL concentration. For 1500mg vials, 5–10mL is typical. Swirl gently — do not shake.
Storage reference
Lyophilised: 2–8°C, stable 12–18 months. Reconstituted: 2–8°C, protect from light, use within 14–21 days due to oxidation sensitivity.
Minimum documentation standard
- Record the lot identifier and review its matching analytical documentation.
- Use aseptic technique and record diluent, final volume and calculated concentration.
- Label preparation date, storage conditions and any light or freeze–thaw restrictions.
- Inspect before each use and investigate unexpected colour, clarity or particulate changes.
Limitations & safety
Injectable and IV glutathione can cause sulphur-like taste or odour shortly after administration.
Asthma exacerbation has been reported in susceptible individuals.
Reconstituted glutathione oxidises over time; use promptly and protect from light.
Research use only
This field note is an educational literature summary, not medical advice or a recommendation for human use. Safety statements are limited by the quality and duration of the available evidence.
Continue reading